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Case ReportsBiventricular assist device implantation as bridge to transplantation
after Mustard procedureAbdul Rahman Dakkak, MD, Angelo M. Dell’Aquila, MD, Juergen R. Sindermann, PhD, and
Andreas Rukosujew, PhD, Muenster, GermanyWe present a case of a 30-year-old man who underwent
an atrial switch operation (Mustard procedure) at age 5
months due to a transposition of the great arteries.
At age 29 years, several hospitalizations were required
due to recurrent cardiac decompensation with dyspnea
and leg swelling. Cardiac magnetic resonance imaging
showed a highly reduced systolic function of the hypertro-
phied systemic ventricle (ejection fraction, 16%) and the
significantly dilated pulmonary ventricle (ejection fraction,
10%). The patient’s clinical condition deteriorated rapidly
with beginning multiorgan failure. Medical management
was only partially successful; therefore, we opted for
biventricular support. A HeartWare ventricular assist device
(VAD) pump (HeartWare Inc, Framingham, Mass) was
chosen for its small size and for the consequent possibility
of intrapericardial implantation.FIGURE 1. Upper panel, The left ventricular assist device (systemic
ventricle) and the anatomical structures. Lower panel, The left ventricular
assist device (systemic ventricle) and the right ventricular assist device (sub-CLINICAL SUMMARY
Median resternotomy and dissection of cardiac adhesions
were performed after starting the extracorporeal circulation.
Connection to the heart–lung machine was achieved via
cannulation of the left common femoral artery and the
femoral vein. The HeartWare pump housing was connected
to the apex of the anatomical left ventricle (pulmonary
ventricle), whereas the outflow cannula was connected to
the pulmonary artery. This was narrowed just before the
anastomosis with the pulmonary artery using a Hegar
dilator to a diameter of 7 mm. A second HeartWare pump
was placed in the area of the inferior wall of the anatomical
right ventricle (systemic ventricle) (Figure 1). Before VAD
placement all visible trabeculations that could have poten-
tially compromised blood flow were resected. Moreover,
because of ventricular dilation no polytetrafluoroethylene
felt ring between sewing ring and inflow cannula was neces-
sary. This, as described in our previous report,1 allowed apulmonary ventricle). LVAD, Left ventricular assist device; RVAD, right
ventricular assist device; RV, right ventricle; PA, pulmonary artery.
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The Journal of Thoracic and Carshorter length of the inflow cannula in the regular right
VAD implantation.
During the patient’s intensive care unit stay his
hemodynamic functions were stable, with a mean blood
pressure of 60 to 70 mm Hg, achieved through right
VAD and left VAD flows of 3.0 and 3.5 to 3.7 L/min,
respectively (Figure 2). On the 10th postoperative day adiovascular Surgery c Volume 148, Number 6 e243
FIGURE 2. Chest radiograph showing both ventricular assist devices and
their position. LVAD, Left ventricular assist device;RVAD, right ventricular
assist device.
Case Reportstransient tracheotomy was performed because of prolonged
respiratory weaning. A postoperative initial elevation in
bilirubin values decreased spontaneously during the first
2 weeks. The patient was increasingly mobile and on the
25th postoperative day the tracheal tube was removed.
Warfarin and aspirin were administrated for anticoagulation
(international normalized ratio target, 2.5-3) and antiplate-
let therapy, respectively. After 6 months of follow-up the
patient is in good condition on an outpatient basis.
DISCUSSION
VAD implantation with a single pump for supporting the
right (systemic) ventricle may not be sufficient in the
presence of biventricular failure. In this regard, biventricu-
lar support has to be preferred. Considering the anatomic
characteristics of patients after Mustard procedure,
biventricular VAD implantation constitutes a special
surgical challenge. The moderator band and the trabecula-
tion of the morphologic right ventricle represent a
demanding surgical issue for the insertion of the left VAD
pump (systemic ventricle). The apex of the right (systemic)
ventricle contains many trabeculae that could limit the
inflow leading to low drainage. In addition, the size of the
used VAD plays an important role in the surgical procedure.e244 The Journal of Thoracic and Cardiovascular SurSpecial attention is required in placing the inflow pump in
the right ventricle to guarantee an unobstructed flow in
and out of the device. Wiklund and colleagues2 reported a
case of HeartMate I (Thoratec Corp, Pleasanton, Calif)
left VAD (systemic ventricle) implantation in a patient
aged 15 years after Mustard operation. Due to the anatomic
and topographic factors, the HeartMate I left VAD
(systemic ventricle) had to be implanted back to front,
with the inflow directed toward the diaphragmatic wall of
the right ventricle and the outflow toward the apex region.
In our case, this was not necessary because of the smaller
HeartWare pump dimensions.
Another concern is pulmonary outflow. To increase the
pump afterload and to avoid excessive lung perfusion
with possible consequent pulmonary edema, the outflow
graft of the right VADwas narrowed1 to a diameter of 7mm.
There are many studies on the use of biventricular assist
devices in patients with acquired cardiomyopathy of
different etiopathogenesis.3,4 There are also several
reports on systemic VADs in patients after Mustard
procedure.5 However to our best knowledge, a comparable
case has not yet been described in the literature.
As a result, the use of biventricular cardiac support
systems is no longer a rarity. Treatment of adult patients
with congenital heart failure who underwent surgical
correction in childhood is a major challenge for cardiolo-
gists and surgeons. With an increasing number of patients
requiring heart transplantation and the presence of donor
shortages, biventricular mechanical support could represent
a valid alternative in patients with complex congenital heart
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